TRV

Third Rock Ventures Portfolio holdings

AUM $1.07B
1-Year Est. Return 201.55%
This Quarter Est. Return
1 Year Est. Return
+201.55%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.07B
AUM Growth
+$110M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
5
New
Increased
Reduced
Closed

Top Buys

1 +$622M

Top Sells

1 +$98.6M
2 +$95.6M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GBT
1
DELISTED
Global Blood Therapeutics, Inc.
GBT
$622M 58.1%
+14,760,900
SAGE
2
DELISTED
Sage Therapeutics
SAGE
$273M 25.46%
6,442,916
-2,330,157
BPMC
3
DELISTED
Blueprint Medicines
BPMC
$158M 14.73%
7,393,059
CARM
4
DELISTED
Carisma Therapeutics
CARM
$11.7M 1.09%
242,080
LRMR icon
5
Larimar Therapeutics
LRMR
$276M
$6.72M 0.63%
17,531
-249,306